Carl Ola Landgren

Sylvester Comprehensive Cancer Center at University of Miami, USA

Ola Landgren is Professor of Medicine at Sylvester Comprehensive Cancer Center at University of Miami, Miami, Florida. He is the Chief of the Myeloma Program and the Leader for the Experimental Therapeutics Program. He previously served as the Chief of the Myeloma Program at Memorial Sloan Kettering Cancer Center in New York City, and prior to that he served as the Chief of the Myeloma Program at National Cancer Institute at the National Institutes of Health in Bethesda, Maryland. He has a longstanding interest and track-record in drug development, translational science, and he is one of the pioneers the development of minimal residual disease (MRD) assays in multiple myeloma.